Volume 95, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



It is challenging to find safe, nonscarring and noninvasive treatment of facial cutaneous leishmaniasis (CL) in children. Herein, we report a child with CL from a region endemic for , whose lesion persisted after treatment with oral fluconazole but responded to topical paromomycin. Paromomycin should be considered early for treatment of Old World CL and is a well-tolerated and effective mode of therapy for facial lesions.


Article metrics loading...

Loading full text...

Full text loading...



  1. World Health Organization, 2015. Leishmaniasis: Situation and Trends and Leishmaniasis Resources. Available at: http://www.who.int/neglected_diseases/diseases/en/, http://www.who.int/gho/neglected_diseases/leishmaniasis/en/, and http://www.who.int/leishmaniasis/resources/AFGHANISTAN.pdf. Accessed October 15, 2015.
  2. Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S, , 2007. Cutaneous leishmaniasis. Lancet Infect Dis 7: 581596.[Crossref]
  3. Crogan J, Gunasekera H, Wood N, Sheikh M, Isaacs D, , 2010. Management of Old World cutaneous leishmaniasis in refugee children. Pediatr Infect Dis J 29: 357359.
  4. Piscopo TV, Mallia AC, , 2006. Leishmaniasis. Postgrad Med J 82: 649657.[Crossref]
  5. Sklavos AV, Walls T, Webber MT, Watson AB, , 2010. Cutaneous leishmaniasis in a child treated with oral fluconazole. Australas J Dermatol 51: 195197.[Crossref]
  6. Toubiana J, Armengaud JB, Dupouy Camet J, Gendrel D, , 2006. Oral fluconazole treatment for extensive cutaneous leishmaniasis in an 11-year-old child. Pediatr Infect Dis J 25: 10831084.[Crossref]
  7. Baron S, Laube S, Raafat F, Moss C, , 2004. Cutaneous leishmaniasis in a Kosovan child treated with oral fluconazole. Clin Exp Dermatol 29: 546547.[Crossref]
  8. Aerts O, Duchateau N, Willemse P, Lambert J, , 2015. Cutaneous leishmaniasis: treatment with low-dose oral fluconazole with an excellent cosmetic result. Pediatr Dermatol 32: 154155.[Crossref]
  9. Alrajhi AA, Ibrahim EA, De Vol EB, Khairat M, Faris RM, Maguire JH, , 2002. Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major . N Engl J Med 346: 891895.[Crossref]
  10. Emad M, Hayati F, Fallahzadeh MK, Namazi MR, , 2011. Superior efficacy of oral fluconazole 400 mg daily versus oral fluconazole 200 mg daily in the treatment of cutaneous Leishmania major infection: a randomized clinical trial. J Am Acad Dermatol 64: 606608.[Crossref]
  11. Solomon M, Schwartz E, Pavlotsky F, Sakka N, Barzilai A, Greenberger S, , 2014. Leishmania tropica in children: a retrospective study. J Am Acad Dermatol 71: 271277.[Crossref]
  12. Ben Salah A, Ben Messaoud N, Guedri E, Zaatour A, Ben Alaya N, Bettaieb J, Gharbi A, Belhadj Hamida N, Boukthir A, Chlif S, Abdelhamid K, El Ahmadi Z, Louzir H, Mokni M, Morizot G, Buffet P, Smith PL, Kopydlowski KM, Kreishman-Deitrick M, Smith KS, Nielsen CJ, Ullman DR, Norwood JA, Thorne GD, McCarthy WF, Adams RC, Rice RM, Tang D, Berman J, Ransom J, Magill AJ, Grogl M, , 2013. Topical paromomycin with or without gentamicin for cutaneous leishmaniasis. N Engl J Med 368: 524532.[Crossref]
  13. Neal RA, Allen S, McCoy N, Olliaro P, Croft SL, , 1995. The sensitivity of Leishmania species to aminosidine. J Antimicrob Chemother 35: 577584.[Crossref]
  14. Kim DH, Chung HJ, Bleys J, Ghohestani RF, , 2009. Is paromomycin an effective and safe treatment against cutaneous leishmaniasis? A meta-analysis of 14 randomized controlled trials. PLoS Negl Trop Dis 3: e381.[Crossref]

Data & Media loading...

  • Received : 29 Nov 2015
  • Accepted : 04 Jul 2016

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error